相关临床试验
0
0 进行中
药物批准
0
批准总数
监管机构
0
监管机构数
成立时间
N/A
暂无试验阶段数据
暂无试验数据
暂无试验数据
暂无批准数据
- Nearly half (48%) of Canadians reported receiving none of the surveyed respiratory vaccines for influenza, COVID-19, pneumococcal disease, or RSV in the past year. - Helping protect vulnerable individuals and older family members ranked among the leading motivators for vaccination, revealing a gap between intention and action. - Familiarity with influenza (98%) and COVID-19 (99%) was nearly universal, while awareness of RSV (71%) and pneumococcal disease (66%) lagged considerably. - Almost two-thirds (64%) of respondents were unsure or unlikely to proactively discuss respiratory illness prevention with a healthcare professional in the next six months.
- More than three in five Americans (62%) support biomedical animal research when veterinarians supervise to ensure animal welfare, with only 13% opposed. - A majority accept animal research for severe conditions including cancer (56%), rare diseases (52%), and brain/nervous system conditions (50%) when no alternatives exist. - Nearly two-thirds (63%) disagree that humans should replace animals in medical testing, and only 29% believe AI can currently replace animal research. - The Ipsos-conducted survey of 2,011 U.S. adults, commissioned by Oregon Voices for Biomedical Research, carries a credibility interval of ±2.5 percentage points.
- A clinical trial by University of Hasselt researchers found that people with well-controlled type 2 diabetes can consume 100% orange juice at breakfast without adversely affecting blood glucose levels. - The study compared whole oranges, 100% orange juice, and sugary drinks paired with high-carbohydrate breakfast, finding no significant differences in blood sugar response among the three options. - Researchers attributed the lack of impact to the dominant glucose response from bread in the standard breakfast, making fruit sugars inconsequential to overall blood sugar levels. - The findings suggest 100% orange juice can serve as a convenient alternative to whole fruit for diabetics, providing essential vitamins and minerals without compromising glycemic control.
- A new LEO Pharma survey finds 65% of dermatology providers acknowledge significant knowledge gaps in distinguishing chronic hand eczema (CHE) from atopic dermatitis, highlighting a critical need for education. - The study reveals that 51% of providers consider current moderate-to-severe atopic dermatitis treatments insufficient for CHE management, with no FDA-approved treatments currently available. - Survey data shows complex treatment patterns, with 61% of providers prescribing 3-4 different medications for moderate-to-severe CHE patients, while facing challenges with medication adherence.
